Interleukin-6: on target for disease and approaching the bedside
Elias, J.A.
Journal of Laboratory and Clinical Medicine 120(5): 672-674
1992
ISSN/ISBN: 0022-2143 PMID: 1431494 Document Number: 402911
Document emailed within 1 workday
Related Documents
Stenderup, K.; Rosada, C.; Dam, T.N. 2008: Interleukin-20--a new target in psoriasis treatment Ugeskrift for Laeger 170(36): 2777-2781Koczorek, M. 2014: Interleukin 17, a promising target for the treatment of psoriasis Medizinische Monatsschrift für Pharmazeuten 37(1): 34-35
Wang, Z.; Liang, G.; Fu, S. 1998: The target--gene expression of interleukin--12 in HepG2 cells Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 12(4): 306-309; 329
Waldmann, T.A.; Goldman, C.K. 1989: The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 14(5 Suppl 2: 45-53
London, L.; McKearn, J.P. 1990: The dual regulatory role of interleukin 4 is mediated through a direct effect on the target cell Experimental Hematology 18(10): 1059-1063
Dayer, J.-M. 2002: Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? Journal of Rheumatology. Suppl 65: 10-15
Chu, C.-J.; Lu, R.-H.; Wang, S.-S.; Chang, F.-Y.; Lin, S.-Y.; Yang, C.-Y.; Lin, H.-C.; Chang, C.-Y.; Wu, M.-Y.; Lee, S.-D. 2007: Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease Hepato-Gastroenterology 54(79): 2045-2048
Mihaela Spîrchez; Sama, G.şca; Ianc, M.; Bolba, C.; Miu, N. 2012: Relation of Interleukin-6, TNF-Alpha and Interleukin-1α with Disease Activity and Severity in Juvenile Idiopathic Arthritis Patients Clinical Laboratory 58(3-4): 253-260
Yan, H-bing.; Li, W-zheng.; Zhao, H-jun.; Song, L.; Zheng, B.; Zhou, P.; Liu, C. 2011: Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease Zhonghua Xin Xue Guan Bing Za Zhi 39(2): 142-146
Rampart, M.; Herman, A.G.; Grillet, B.; Opdenakker, G.; Van Damme, J. 1992: Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease Laboratory Investigation; a Journal of Technical Methods and Pathology 66(4): 512-518
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Kierszenbaum, F.; Lopez, H.M.; Sztein, M.B. 1996: Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes Journal of Parasitology 82(4): 652-656
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36
Wissing, K.M.; Desalle, F.; Abramowicz, D.; Willems, F.; Leo, O.; Goldman, M.; Alegre, M.L. 1999: Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice Transplantation 68(5): 677-684
Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551
Réglier-Poupet, H.; Hakim, J.; Gougerot-Pocidalo, M.A.; Elbim, C. 1998: Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood European Cytokine Network 9(4): 633-638
Yokota, T. 2005: Class i cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 187-192
Qiu, H.B.; Chen, D.C.; Pan, J.Q.; Liu, D.W.; Ma, S. 1999: Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 in mouse alveolar macrophages Zhongguo Yao Li Xue Bao 20(3): 271-275
Kuntz, H.D. 1983: Differential diagnosis at the bedside. Inflammatory intestinal disease or short bowel syndrome? Münchener Medizinische Wochenschrift 125(17): 65
Ricciardi, C.A.; Gnudi, L. 2019: Endoplasmic Reticulum stress in chronic kidney disease. new molecular targets from bench to the bedside Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 36(6)